When will the U.S. flinch at cancer drug prices?
Vanchieri
Cori
C
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000191:economics; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry; D017850:Economics, Pharmaceutical; D006297:Health Services Accessibility; D006779:Hospitals, Public / Q000191:economics; D006801:Humans; D011306:Prescription Fees; D014481:United States
D000970:Antineoplastic Agents